Skip to main content
Clinical Trials/NCT01858246
NCT01858246
Completed
N/A

A Randomised Controlled Trial Comparing Bone Anchored Hearing Aid With Bonebridge

Ninewells Hospital1 site in 1 country3 target enrollmentJanuary 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hearing Loss, Conductive
Sponsor
Ninewells Hospital
Enrollment
3
Locations
1
Primary Endpoint
Speech audiogram result at 6 months after switch on at 60 dBA in quiet using AB word lists
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The Bonebridge is a new bone conducting implantable hearing aid. The investigators plan to randomize patients to receive either the Bonebridge or a conventional bone conducting hearing device. The investigators will then compare the surgical and audiological outcomes of the two groups.

Detailed Description

The new Bonebridge fully implanted, except for an external sound processor. It does not have any percutaneous parts like the Bone Anchored Hearing Aid. The investigators believe that this may improve wound healing and reduce problems with wound infection and skin overgrowth seen in Bone Anchored Hearing Aids. There may also be audiological improvements by the use of the Bonebridge as the physical separation of the vibrating part from the sound processor should reduce feedback. The company also claims other audiological improvements in the Bonebridge. The investigators wish to demonstrate whether this is actually the case by performing a study directly comparing the outcomes of the two groups.

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
December 31, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Stephen Jones

Consultant ENT Surgeon

Ninewells Hospital

Eligibility Criteria

Inclusion Criteria

  • Conductive Hearing Loss within criteria for Bonebridge

Exclusion Criteria

  • Pregnancy

Outcomes

Primary Outcomes

Speech audiogram result at 6 months after switch on at 60 dBA in quiet using AB word lists

Time Frame: Up to 1 year post-operatively

We will record and compare the standard speech audiometry results at a specific sound level in order to make a direct comparison of devices

Secondary Outcomes

  • Speech audiogram result at 60 dB A in noise using AB word lists(Up to 1 year after implantation)
  • Patient reported outcome data(Up to 1 year following implantation)
  • Time from surgery to device switch-on(Up to 3 months)
  • Number of patient episodes required during study period(1 year from implantation)
  • Time to complete wound healing(Up to 3 months from implantation)

Study Sites (1)

Loading locations...

Similar Trials